125 related articles for article (PubMed ID: 15170672)
1. Genetic abnormalities in plasma DNA of patients with lung cancer and other respiratory diseases.
Khan S; Coulson JM; Woll PJ
Int J Cancer; 2004 Jul; 110(6):891-5. PubMed ID: 15170672
[TBL] [Abstract][Full Text] [Related]
2. Plasma DNA microsatellite panel as sensitive and tumor-specific marker in lung cancer patients.
Beau-Faller M; Gaub MP; Schneider A; Ducrocq X; Massard G; Gasser B; Chenard MP; Kessler R; Anker P; Stroun M; Weitzenblum E; Pauli G; Wihlm JM; Quoix E; Oudet P
Int J Cancer; 2003 Jun; 105(3):361-70. PubMed ID: 12704670
[TBL] [Abstract][Full Text] [Related]
3. Detection of microsatellite alterations in the DNA isolated from tumor cells and from plasma DNA of patients with lung cancer.
Bruhn N; Beinert T; Oehm C; Jandrig B; Petersen I; Chen XQ; Possinger K; Fleischhacker M
Ann N Y Acad Sci; 2000 Apr; 906():72-82. PubMed ID: 10818600
[TBL] [Abstract][Full Text] [Related]
4. Detecting lung cancer in plasma with the use of multiple genetic markers.
Andriani F; Conte D; Mastrangelo T; Leon M; Ratcliffe C; Roz L; Pelosi G; Goldstraw P; Sozzi G; Pastorino U
Int J Cancer; 2004 Jan; 108(1):91-6. PubMed ID: 14618621
[TBL] [Abstract][Full Text] [Related]
5. Detection of microsatellite alterations in plasma DNA of non-small cell lung cancer patients: a prospect for early diagnosis.
Sozzi G; Musso K; Ratcliffe C; Goldstraw P; Pierotti MA; Pastorino U
Clin Cancer Res; 1999 Oct; 5(10):2689-92. PubMed ID: 10537330
[TBL] [Abstract][Full Text] [Related]
6. Genetic alterations in bronchial mucosa and plasma DNA from individuals at high risk of lung cancer.
Allan JM; Hardie LJ; Briggs JA; Davidson LA; Watson JP; Pearson SB; Muers MF; Wild CP
Int J Cancer; 2001 Feb; 91(3):359-65. PubMed ID: 11169960
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
[TBL] [Abstract][Full Text] [Related]
8. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
[TBL] [Abstract][Full Text] [Related]
9. Genetic heterogeneity in lung and colorectal carcinoma as revealed by microsatellite analysis in plasma or tumor tissue DNA.
Beau-Faller M; Weber JC; Schneider A; Guèrin E; Gasser B; Ducrocq X; Jaeck D; Wihlm JM; Quoix E; Gaub MP
Cancer; 2003 May; 97(9):2308-17. PubMed ID: 12712488
[TBL] [Abstract][Full Text] [Related]
10. 3p microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer.
Carpagnano GE; Foschino-Barbaro MP; Mulé G; Resta O; Tommasi S; Mangia A; Carpagnano F; Stea G; Susca A; Di Gioia G; De Lena M; Paradiso A
Am J Respir Crit Care Med; 2005 Sep; 172(6):738-44. PubMed ID: 15947287
[TBL] [Abstract][Full Text] [Related]
11. Microsatellite alteration at chromosome 3p loci in neuroendocrine and non-neuroendocrine lung tumors. Histogenetic and clinical relevance.
Hurr K; Kemp B; Silver SA; el-Naggar AK
Am J Pathol; 1996 Aug; 149(2):613-20. PubMed ID: 8701999
[TBL] [Abstract][Full Text] [Related]
12. Cell-free DNA as a prognostic marker in stage I non-small-cell lung cancer patients undergoing stereotactic body radiotherapy.
Bortolin MT; Tedeschi R; Bidoli E; Furlan C; Basaglia G; Minatel E; Gobitti C; Franchin G; Trovò M; De Paoli P
Biomarkers; 2015; 20(6-7):422-8. PubMed ID: 26526078
[TBL] [Abstract][Full Text] [Related]
13. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma.
Kneip C; Schmidt B; Seegebarth A; Weickmann S; Fleischhacker M; Liebenberg V; Field JK; Dietrich D
J Thorac Oncol; 2011 Oct; 6(10):1632-8. PubMed ID: 21694641
[TBL] [Abstract][Full Text] [Related]
14. Microsatellite alterations and TP53 mutations in plasma DNA of small-cell lung cancer patients: follow-up study and prognostic significance.
Gonzalez R; Silva JM; Sanchez A; Dominguez G; Garcia JM; Chen XQ; Stroun M; Provencio M; España P; Anker P; Bonilla F
Ann Oncol; 2000 Sep; 11(9):1097-104. PubMed ID: 11061602
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide screening of genomic alterations and their clinicopathologic implications in non-small cell lung cancers.
Kim TM; Yim SH; Lee JS; Kwon MS; Ryu JW; Kang HM; Fiegler H; Carter NP; Chung YJ
Clin Cancer Res; 2005 Dec; 11(23):8235-42. PubMed ID: 16322280
[TBL] [Abstract][Full Text] [Related]
16. Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients.
Sozzi G; Conte D; Mariani L; Lo Vullo S; Roz L; Lombardo C; Pierotti MA; Tavecchio L
Cancer Res; 2001 Jun; 61(12):4675-8. PubMed ID: 11406535
[TBL] [Abstract][Full Text] [Related]
17. p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.
Bearzatto A; Conte D; Frattini M; Zaffaroni N; Andriani F; Balestra D; Tavecchio L; Daidone MG; Sozzi G
Clin Cancer Res; 2002 Dec; 8(12):3782-7. PubMed ID: 12473590
[TBL] [Abstract][Full Text] [Related]
18. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
[TBL] [Abstract][Full Text] [Related]
19. [Comparative genomic hybridization of bronchial carcinomas and their metastases].
Petersen I; Petersen S; Bockmühl U; Schwendel A; Wolf G; Dietel M
Verh Dtsch Ges Pathol; 1997; 81():297-305. PubMed ID: 9474883
[TBL] [Abstract][Full Text] [Related]
20. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
Paci M; Maramotti S; Bellesia E; Formisano D; Albertazzi L; Ricchetti T; Ferrari G; Annessi V; Lasagni D; Carbonelli C; De Franco S; Brini M; Sgarbi G; Lodi R
Lung Cancer; 2009 Apr; 64(1):92-7. PubMed ID: 18804892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
